Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Incremental value of 18F-FDG PET/CT in therapeutic decision-making of potentially curable esophageal adenocarcinoma.

Purandare NC, Pramesh CS, Karimundackal G, Jiwnani S, Agrawal A, Shah S, Kulkarni M, Laskar SG, Rangarajan V.

Nucl Med Commun. 2014 Aug;35(8):864-9. doi: 10.1097/MNM.0000000000000137.

PMID:
24751701
[PubMed - in process]
2.

Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography.

Meltzer CC, Luketich JD, Friedman D, Charron M, Strollo D, Meehan M, Urso GK, Dachille MA, Townsend DW.

Clin Nucl Med. 2000 Nov;25(11):882-7.

PMID:
11079584
[PubMed - indexed for MEDLINE]
3.

The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation.

Brush J, Boyd K, Chappell F, Crawford F, Dozier M, Fenwick E, Glanville J, McIntosh H, Renehan A, Weller D, Dunlop M.

Health Technol Assess. 2011 Sep;15(35):1-192, iii-iv. doi: 10.3310/hta15350. Review.

PMID:
21958472
[PubMed - indexed for MEDLINE]
Free Article
4.

Role of 18F-FDG PET/CT in identifying distant metastatic disease missed by conventional imaging in patients with locally advanced breast cancer.

Manohar K, Mittal BR, Bhoil A, Bhattacharya A, Singh G.

Nucl Med Commun. 2013 Jun;34(6):557-61. doi: 10.1097/MNM.0b013e328360d910.

PMID:
23549551
[PubMed - indexed for MEDLINE]
5.

Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.

Manohar K, Mittal BR, Senthil R, Kashyap R, Bhattacharya A, Singh G.

Nucl Med Commun. 2012 Jun;33(6):591-6. doi: 10.1097/MNM.0b013e3283516716.

PMID:
22334135
[PubMed - indexed for MEDLINE]
6.

Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.

Kanzaki R, Higashiyama M, Maeda J, Okami J, Hosoki T, Hasegawa Y, Takami M, Kodama K.

Interact Cardiovasc Thorac Surg. 2010 Jun;10(6):1009-14. doi: 10.1510/icvts.2009.227538. Epub 2010 Mar 2.

PMID:
20197344
[PubMed - indexed for MEDLINE]
Free Article
7.

The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma.

Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K.

Cancer. 2005 Jan 1;103(1):148-56.

PMID:
15558794
[PubMed - indexed for MEDLINE]
Free Article
8.

High-grade endometrial cancer: value of [(18)F]FDG PET/CT in preoperative staging.

Picchio M, Mangili G, Samanes Gajate AM, De Marzi P, Spinapolice EG, Mapelli P, Giovacchini G, Sigismondi C, Viganò R, Sironi S, Messa C.

Nucl Med Commun. 2010 Jun;31(6):506-12. doi: 10.1097/MNM.0b013e328337cb47.

PMID:
20168262
[PubMed - indexed for MEDLINE]
9.

Clinical usefulness of 18F-FDG PET/CT in the restaging of esophageal cancer after surgical resection and radiotherapy.

Sun L, Su XH, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H.

World J Gastroenterol. 2009 Apr 21;15(15):1836-42.

PMID:
19370780
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Multiple primary malignant tumors of upper gastrointestinal tract: a novel role of 18F-FDG PET/CT.

Sun L, Wan Y, Lin Q, Sun YH, Zhao L, Luo ZM, Wu H.

World J Gastroenterol. 2010 Aug 21;16(31):3964-9.

PMID:
20712059
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.

Han A, Xue J, Hu M, Zheng J, Wang X.

Cancer Epidemiol. 2012 Oct;36(5):470-5. doi: 10.1016/j.canep.2012.03.002. Epub 2012 Apr 14.

PMID:
22504050
[PubMed - indexed for MEDLINE]
12.

Clinical value of F-FDG PET/CT in assessing suspicious relapse after rectal cancer resection.

Sun L, Guan YS, Pan WM, Luo ZM, Wei JH, Zhao L, Wu H.

World J Gastrointest Oncol. 2009 Oct 15;1(1):55-61. doi: 10.4251/wjgo.v1.i1.55.

PMID:
21160775
[PubMed]
Free PMC Article
13.

Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: a prospective study.

Katsoulis IE, Wong WL, Mattheou AK, Damani N, Chambers J, Livingstone JI.

Int J Surg. 2007 Dec;5(6):399-403. Epub 2007 Jun 3.

PMID:
17631431
[PubMed - indexed for MEDLINE]
14.

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.

Koolen BB, Vrancken Peeters MJ, Aukema TS, Vogel WV, Oldenburg HS, van der Hage JA, Hoefnagel CA, Stokkel MP, Loo CE, Rodenhuis S, Rutgers EJ, Valdés Olmos RA.

Breast Cancer Res Treat. 2012 Jan;131(1):117-26. doi: 10.1007/s10549-011-1767-9. Epub 2011 Sep 21.

PMID:
21935602
[PubMed - indexed for MEDLINE]
15.

F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.

Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, Lind P.

Invest Radiol. 2003 May;38(5):250-6.

PMID:
12750613
[PubMed - indexed for MEDLINE]
16.

Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making.

Kantorová I, Lipská L, Bêlohlávek O, Visokai V, Trubaĉ M, Schneiderová M.

J Nucl Med. 2003 Nov;44(11):1784-8.

PMID:
14602860
[PubMed - indexed for MEDLINE]
Free Article
17.

Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?

Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY.

J Nucl Med. 2009 Jan;50(1):24-9. doi: 10.2967/jnumed.108.055806. Epub 2008 Dec 17.

PMID:
19091901
[PubMed - indexed for MEDLINE]
Free Article
18.

Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.

Kitagawa Y, Nishizawa S, Sano K, Ogasawara T, Nakamura M, Sadato N, Yoshida M, Yonekura Y.

J Nucl Med. 2003 Feb;44(2):198-206.

PMID:
12571209
[PubMed - indexed for MEDLINE]
Free Article
19.

18F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.

Groheux D, Hindié E, Marty M, Espié M, Rubello D, Vercellino L, Bousquet G, Ohnona J, Toubert ME, Merlet P, Misset JL.

Eur J Radiol. 2014 Jun 17. pii: S0720-048X(14)00295-2. doi: 10.1016/j.ejrad.2014.05.037. [Epub ahead of print]

PMID:
24985086
[PubMed - as supplied by publisher]
20.

Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma.

Kibel AS, Dehdashti F, Katz MD, Klim AP, Grubb RL, Humphrey PA, Siegel C, Cao D, Gao F, Siegel BA.

J Clin Oncol. 2009 Sep 10;27(26):4314-20. doi: 10.1200/JCO.2008.20.6722. Epub 2009 Aug 3.

PMID:
19652070
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk